To view the PDF file, sign up for a MySharenet subscription.

ADCOCK INGRAM HOLDINGS LIMITED - Audited Group financial results for the year ended 30 June 2024 and cash dividend declaration

Release Date: 22/08/2024 07:05
Code(s): AIP     PDF:  
Wrap Text
Audited Group financial results for the year ended 30 June 2024 and cash dividend declaration

Adcock Ingram Holdings Limited
(Incorporated in the Republic of South Africa)
(Registration number 2007/016236/06)
Share code: AIP ISIN: ZAE000123436
("Adcock Ingram" or "the Company" or "the Group")

Audited Group financial results for the year ended 30 June 2024 and cash dividend declaration

Revenue +6%
Trading profit +4%
HEPS +10%
Final dividend declared: 150 cents per share
Share buyback: 6.0 million shares
B-BBEE level 2

                                                          Change     Audited     Audited 
                                                               %        2024        2023 
Revenue                                         (R'000)        6   9 643 128   9 131 852 
Gross profit                                    (R'000)        1   3 218 532   3 187 020 
Trading profit                                  (R'000)        4   1 229 496   1 180 475 
Operating profit                                (R'000)      (6)   1 064 824   1 135 527 
Headline earnings per share                     (cents)       10       616.6       561.3 
Basic earnings per share                        (cents)      (4)       539.6       561.3 
Total assets                                    (R'000)            8 354 883   8 262 534 
Net asset value per share                       (cents)              3 688.1     3 526.9 
Interim dividend declared per share             (cents)                125.0       125.0 
Final dividend declared per share               (cents)                150.0       125.0 
Segment revenue                                                             
Consumer                                        (R'000)        3   1 701 856   1 654 903 
OTC                                             (R'000)        8   2 461 656   2 282 422 
Prescription                                    (R'000)        4   3 429 809   3 294 379 
Hospital                                        (R'000)        8   2 049 292   1 899 225 
Segment trading profit                                                                   
Consumer                                        (R'000)        2     362 398     356 831 
OTC                                             (R'000)       10     383 585     348 590 
Prescription                                    (R'000)       10     351 913     320 118 
Hospital                                        (R'000)     (16)     128 446     152 094 

The Board of Directors is very pleased with the financial results. A good trading performance, 
coupled with excellent cost control, resulted in the business delivering double-digit HEPS growth.
Furthermore, strong cash generation facilitated the continued return of value to shareholders,
including the repurchase of 6 million shares and 10% growth in dividends. The Company increased its
share and maintained its position as the leading pharmaceutical player in the South African private market.

Prospects

We are encouraged by the positive sentiment generated by the formation of a Government of
National Unity (GNU). This development, along with the possibility of the Reserve Bank reducing
interest rates due to inflation rates improving and the good progress on structural reforms in the 
electricity and rail sectors, are positive indications for the economy. However, we expect that a
significant recovery in consumer spend will take some time should the abovementioned factors 
remain favourable. Furthermore, the financial health of the business remains subject to the 
performance of the currency and the ability to obtain selling price increases, both in the regulated
and non-regulated portfolios.

The Board remains committed to seeking additional affordable brands, as reflected by the recently 
acquired Dermopal, to expand the non price-regulated portfolio, and pursuing partnerships with
respected multinational companies.

Dividend distribution

The Board has declared a final gross cash dividend out of income reserves of 150.0 cents per share in 
respect of the year ended 30 June 2024. The South African dividend tax ("DT") rate is 20% and the
net dividend payable to shareholders who are not exempt from DT is 120.0 cents per share. Adcock
Ingram currently has 161 300 000 ordinary shares in issue and qualifying for ordinary dividends. 
The Company's income tax reference number is 9528/919/15/3.

The salient dates for the distribution are detailed below:

Last date to trade cum distribution                              Tuesday, 17 September 2024
Shares trade ex distribution                                     Wednesday, 18 September 2024
Record date                                                      Friday, 20 September 2024
Payment date                                                     Monday, 23 September 2024

Share certificates may not be dematerialised or rematerialised between Wednesday, 18 September 2024 
and Friday, 20 September 2024, both dates inclusive.

N Madisa                                                         AG Hall
Chairperson                                                      Chief Executive Officer

Approved by the Board: 21 August 2024
SENS release date: 22 August 2024
Company secretary M Phalafala
Registered office 1 New Road, Midrand, 1682 
Postal address Private Bag X69, Bryanston, 2021

Transfer secretaries Computershare Investor Services Proprietary Limited, Rosebank Towers, 
15 Biermann Avenue, Rosebank, Johannesburg, 2196. Private Bag X9000, Saxonwold, 2132

Auditors PricewaterhouseCoopers Inc, 4 Lisbon Lane, Waterfall, 2090

Sponsor Rand Merchant Bank (a division of FirstRand Bank Limited), 1 Merchant Place, 
corner Fredman Drive and Rivonia Road, Sandton, 2196

Bankers Nedbank Limited, 135 Rivonia Road, Sandown, Sandton, 2146. Rand Merchant Bank, 
1 Merchant Place, corner Fredman Drive and Rivonia Road, Sandton, 2196. Investec Bank Limited, 
100 Grayston Drive, Sandton, 2146.

The Group's annual financial statements, which include the unqualified audit opinion of 
PricewaterhouseCoopers Inc, is available through the JSE's cloudlink at
https://senspdf.jse.co.za/documents/2024/JSE/ISSE/AIP/June2024.pdf and on the Company's
website at www.adcock.com/investors/financialreports, together with the Group's summary financial 
statements. Any investment decision should be based on a consideration of the Group's annual
financial statements, as the information in this results announcement does not provide all of the details.

Date: 22-08-2024 07:05:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.